Related references
Note: Only part of the references are listed.Virus-Like Particles Containing the E2 Core Domain of Hepatitis C Virus Generate Broadly Neutralizing Antibodies in Guinea Pigs
Joey McGregor et al.
JOURNAL OF VIROLOGY (2022)
Plant-Based Vaccines in Combat against Coronavirus Diseases
Benita Ortega-Berlanga et al.
VACCINES (2022)
Deciphering Vaccines for COVID-19: where do we stand today?
Tushar Baviskar et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2021)
Coronavirus Disease 2019 Vaccine Development: An Overview
Riyadi Sumirtanurdin et al.
VIRAL IMMUNOLOGY (2021)
SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?
Saborni Chakraborty et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Review on Up-to-Date Status of Candidate Vaccines for COVID-19 Disease
Tafere Mulaw Belete
INFECTION AND DRUG RESISTANCE (2021)
The Johnson & Johnson Vaccine for COVID-19
Edward H. Livingston et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial
Peter Richmond et al.
LANCET (2021)
S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates
Joshua G. Liang et al.
NATURE COMMUNICATIONS (2021)
CHINA'S COVID VACCINES ARE GOING GLOBAL - BUT QUESTIONS REMAIN
Smriti Mallapaty
NATURE (2021)
Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021
David K. Shay et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Potent Neutralization Antibodies Induced by a Recombinant Trimeric Spike Protein Vaccine Candidate Containing PIKA Adjuvant for COVID-19
Jiao Tong et al.
VACCINES (2021)
COVID-19 vaccines
Duduzile Ndwandwe et al.
CURRENT OPINION IN IMMUNOLOGY (2021)
The CEPI centralised laboratory network: supporting COVID-19 vaccine development
Arun Kumar et al.
LANCET (2021)
Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial
Shipo Wu et al.
LANCET INFECTIOUS DISEASES (2021)
Neutralizing Antibodies against SARS-CoV-2, Anti-Ad5 Antibodies, and Reactogenicity in Response to Ad5-nCoV (CanSino Biologics) Vaccine in Individuals with and without Prior SARS-CoV-2
Jorge Hernandez-Bello et al.
VACCINES (2021)
Advances in the design and development of SARS-CoV-2 vaccines
Xue-Liang Peng et al.
MILITARY MEDICAL RESEARCH (2021)
An overview of current COVID-19 vaccine platforms
Abdou Nagy et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial
Pablo Tebas et al.
ECLINICALMEDICINE (2021)
Current advances in the development of SARS-CoV-2 vaccines
Annoor Awadasseid et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments
Yashpal Singh Malik et al.
VETERINARY QUARTERLY (2020)
Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
Syed Faraz Ahmed et al.
VIRUSES-BASEL (2020)
The promise of mRNA vaccines: a biotech and industrial perspective
Nicholas A. C. Jackson et al.
NPJ VACCINES (2020)
Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease
Liu Wei et al.
CHINESE MEDICAL JOURNAL (2020)
Race for a Coronavirus Vaccine
Delthia Ricks
Genetic Engineering & Biotechnology News (2020)
A Review of SARS-CoV-2 and the Ongoing Clinical Trials
Yung-Fang Tu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Global efforts on vaccines for COVID-19: Since, sooner or later, we all will catch the coronavirus
Raju Mukherjee
JOURNAL OF BIOSCIENCES (2020)
Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection
Kun Li et al.
MBIO (2020)
Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients
Chek Meng Poh et al.
NATURE COMMUNICATIONS (2020)
Ensuring global access to COVID-19 vaccines
Gavin Yamey et al.
LANCET (2020)
SARS-CoV-2: virus dynamics and host response
Yu Chen et al.
LANCET INFECTIOUS DISEASES (2020)
A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques
Neeltje van Doremalen et al.
SCIENCE ADVANCES (2020)
The COVID-19 vaccine development landscape
Tung Thanh Le et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Developing Covid-19 Vaccines at Pandemic Speed
Nicole Lurie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Trials of BCG vaccine will test for covid-19 protection
Graham Lawton
NEW SCIENTIST (2020)
DNA vaccines: prime time is now
Ebony N. Gary et al.
CURRENT OPINION IN IMMUNOLOGY (2020)
The Novel Insight of SARS-CoV-2 Molecular Biology and Pathogenesis and Therapeutic Options
Arghavan Asghari et al.
DNA AND CELL BIOLOGY (2020)
Mandated Bacillus Calmette-Guerin (BCG) vaccination predicts flattened curves for the spread of COVID-19
Martha K. Berg et al.
SCIENCE ADVANCES (2020)
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Feng-Cai Zhu et al.
LANCET (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti et al.
LANCET (2020)
BCG vaccination early in life does not improve COVID-19 outcome of elderly populations, based on nationally reported data
T. M. Wassenaar et al.
LETTERS IN APPLIED MICROBIOLOGY (2020)
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Mark J. Mulligan et al.
NATURE (2020)
Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS
Kam Lun Hon et al.
PEDIATRIC PULMONOLOGY (2020)
BCG vaccination policy and preventive chloroquine usage: do they have an impact on COVID-19 pandemic?
Abhibhav Sharma et al.
CELL DEATH & DISEASE (2020)
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Denis Y. Logunov et al.
LANCET (2020)
Recombinant protein targeting and opsonizing spike glycoprotein for enhancing SARS-CoV-2 phagocytosis
Latifa Khattabi
MEDICAL HYPOTHESES (2020)
Evolution of the COVID-19 vaccine development landscape
Tung Thanh Le et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Current COVID-19 vaccine candidates: Implications in the Saudi population
AlAnoud TofailAhmed Raja et al.
SAUDI PHARMACEUTICAL JOURNAL (2020)
Coronavirus vaccine development: from SARS and MERS to COVID-19
Yen-Der Li et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
Vaccine development against coronavirus (2003 to present): An overview, recent advances, current scenario, opportunities and challenges
Kirtikumar C. Badgujar et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development
Ayman Mubarak et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus
Chean Yeah Yong et al.
FRONTIERS IN MICROBIOLOGY (2019)
Vaccine against Middle East respiratory syndrome coronavirus
Alimuddin Zumla et al.
LANCET INFECTIOUS DISEASES (2019)
BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity
Rob J. W. Arts et al.
CELL HOST & MICROBE (2018)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial
Feng-Cai Zhu et al.
LANCET (2017)
MERS-CoV spike nanoparticles protect mice from MERS-CoV infection
Christopher M. Coleman et al.
VACCINE (2017)
Middle East Respiratory Syndrome (MERS)
Jennan A. Phillips
Workplace Health & Safety (2017)
Vaccines for the prevention against the threat of MERS-CoV
Lanying Du et al.
EXPERT REVIEW OF VACCINES (2016)
MERS-CoV vaccine candidates in development: The current landscape
Kayvon Modjarrad
VACCINE (2016)
MERS in South Korea and China: a potential outbreak threat?
Shuo Su et al.
LANCET (2015)
Long-Lasting Effects of BCG Vaccination on Both Heterologous Th1/Th17 Responses and Innate Trained Immunity
Johanneke Kleinnijenhuis et al.
JOURNAL OF INNATE IMMUNITY (2014)
mRNA-based therapeutics - developing a new class of drugs
Ugur Sahin et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Effects of mesenchymal stem cell and fibroblast coating on immunogenic potential of prosthetic meshes in vitro
Yue Gao et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2014)
Middle East Respiratory Syndrome Coronavirus (MERS-CoV): A Perpetual Challenge
Sami Al Hajjar et al.
ANNALS OF SAUDI MEDICINE (2013)
Complete Protection against Severe Acute Respiratory Syndrome Coronavirus-Mediated Lethal Respiratory Disease in Aged Mice by Immunization with a Mouse-Adapted Virus Lacking E Protein
Craig Fett et al.
JOURNAL OF VIROLOGY (2013)
Risk in Vaccine Research and Development Quantified
Esther S. Pronker et al.
PLOS ONE (2013)
Return of inactivated whole-virus vaccine for superior efficacy
Yoichi Furuya
IMMUNOLOGY AND CELL BIOLOGY (2012)
Correction: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
Chien-Te Tseng et al.
PLoS One (2012)
A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses
Ming-Wei Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus
RH See et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Vaccine design for severe acute respiratory syndrome coronavirus
YX He et al.
VIRAL IMMUNOLOGY (2005)
Severe acute respiratory syndrome
JSM Peiris et al.
NATURE MEDICINE (2004)
Virus-like particles as immunogens
R Noad et al.
TRENDS IN MICROBIOLOGY (2003)
Share Paper
